Skip to main content

Advertisement

Log in

The renin-angiotensin-aldosterone system in cerebral small vessel disease

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Introduction

Cerebral small vessel disease (SVD) appears on magnetic resonance imaging (MRI) as leukoaraiosis (LA), état criblé (EC), and multiple lacunar infarctions (MLI). Although the pathophysiology of SVD is poorly understood, there is evidence of a genetic contribution. We sought to analyze the influence of the reninangiotensin-aldosterone system (RAAS) on SVD in symptomatic patients from the Génétique de l’Infarctus Cérébral (GENIC) study, including RAAS polymorphisms and circulating angiotensin converting enzyme (ACE).

Methods

Caucasian patients (n = 510) with acute brain infarction (BI) were recruited and MRIs were evaluated for SVD, including LA, EC, and MLI. We considered ACE levels and several polymorphisms, including ACE, angiotensinogen, aldosterone synthase CYP11B2, and angiotensin II receptor type I.

Results

Among the polymorphisms, there were marginal negative associations between aldosterone synthase CYP11B2 -344C against severe EC (adjusted OR, 0.57; 95 % CI, 0.31– 1.05) and severe LA (adjusted OR, 0.54; 95 % CI, 0.30–0.95), both considering -344C dominant. In addition, the frequency of -344C decreased with the number of SVD abnormalities (p = 0.016). Mean plasma ACE was elevated in patients with MLI, but not with LA or EC. The risk of MLI increased gradually with increasing plasma ACE (adjusted OR, 1.25; 95 % CI, 1.02–1.53).

Conclusions

This exploratory study found no strong evidence for RAAS involvement in severe SVD in this population. The whole spectrum of SVD, including EC, MLI, and LA, can be considered as phenotypes for genetic studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Roman G, Erkinjuntti T, Wallin A, et al. (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1:426–436

    Article  PubMed  Google Scholar 

  2. Awad I, Spetzler R, Hodak J, et al. (1986) Incidental subcortical lesions identified on magnetic resonance imaging in the elderly: Correlation with age and risk factors. Stroke 17:1084–1089

    PubMed  CAS  Google Scholar 

  3. Van Swieten JC, van den Hout J, van Ketel B (1991) Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 114:761–774

    Article  PubMed  Google Scholar 

  4. Pico F, Labreuche J, Touboul P, et al. (2005) Intracranial Arterial Dolichoectasia and Small Vessel Disease in Stroke Patients. Ann Neurol 57:472–479

    Article  PubMed  Google Scholar 

  5. Longstreth W, Bernick C, Manolio T, et al. (1998) Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people. Arch Neurol 55:1217–1225

    Article  PubMed  Google Scholar 

  6. Breteler M, Van Swieten JC, Bots M, et al. (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam study. Neurology 44:1246–1252

    PubMed  CAS  Google Scholar 

  7. Ylikoski A, Erkinjuntti T, Raininko R, et al. (1995) White matter hyperintensities on MRI in the neurologically nondiseased elderly: Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 26:1171–1177

    PubMed  CAS  Google Scholar 

  8. Lindgren A, Roijer A, Rudling O (1994) Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. Stroke 25:929–934

    PubMed  CAS  Google Scholar 

  9. Liao D, Cooper L, Cia J, et al. (1996) Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Stroke 27:2262–2270

    PubMed  CAS  Google Scholar 

  10. Hassan A, Hunt B, O’Sullivan (2003) Markers of endothelial dysfunction in lacunar infarction to neurological disorders. Brain 126:424–432

    Article  PubMed  Google Scholar 

  11. Carmelli D, DeCarli C, Swan G, et al. (1989) Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 29:1177–1181

    Google Scholar 

  12. Szolnoki Z, Somogyvari F, Kondacs A, et al. (2004) Specific APO E genotypes in combination with the ACE DD or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis. Acta Neurol Scand 109:222–227

    Article  PubMed  CAS  Google Scholar 

  13. Hassan A, Lansbury A, Catto AJ, et al. (2002) Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J Neurol Neurosurg Psychiatry 72:343–346

    Article  PubMed  CAS  Google Scholar 

  14. Szolnoki Z, Somogyvari F, Kondacs A, et al. (2001) Evaluation of the roles of common genetic mutations in leukoaraiosis. Acta Neurol Scand 104:281–287

    Article  PubMed  CAS  Google Scholar 

  15. Amar K, MacGowan S, Wilcock G, et al. (1998) Are genetic factors important in the aetiology of leukoaraiosis? Int J Geriatr Psych 13:585–590

    Article  CAS  Google Scholar 

  16. Schmidt R, Schmidt H, Fazekas F, et al. (2001) Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small vessel disease-related cerebral abnormalities. Hypertension 38:110–115

    PubMed  CAS  Google Scholar 

  17. Verpillat P, Alpérovitch A, Cambien F, et al. (2001) Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities. Neurology 56:673–675

    PubMed  CAS  Google Scholar 

  18. Schmidt R, Schmidt H, Fazekas F (2000) MRI cerebral white matter lesions and paraoxonase PON1 Polymorphisms; Three-year follow-up of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Biol 20:1811–1816

    PubMed  CAS  Google Scholar 

  19. Hassan A, Gormley K, O’Sullivan M, et al. (2004) Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35:654–659

    Article  PubMed  CAS  Google Scholar 

  20. Brenner D, Labreuche J, Poirier O, et al. (2005) renin-angiotensin-aldosterone system in brain infarction and vascular death. Ann Neurol 58:131–138

    Article  PubMed  CAS  Google Scholar 

  21. Pantano P, Caramia F, Bozzao L, et al. (1999) Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome. Stroke 30:502–507

    PubMed  CAS  Google Scholar 

  22. Scheltens P, Barkhof F, Leys D, et al. (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114:7–12

    Article  PubMed  CAS  Google Scholar 

  23. Isaji M, Mune T, Takada N, et al. (2005) Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2. J Hypertens 23:1149–1157

    Article  PubMed  CAS  Google Scholar 

  24. Fardella C, Rodriguez H, Montero J, et al. (1996) Genetic variation in P450c11AS in Chilean patient with low renin hypertension. J Clin Endocrinol Metab 81:4347–4351

    Article  PubMed  CAS  Google Scholar 

  25. Komiya I, Yamada T, Takara M, et al. (2000) Lys173Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 35:699–703

    PubMed  CAS  Google Scholar 

  26. Matsubara M, Sato H, Nishimura T, et al. (2004) CYP11B2 polymorphisms and home blood pressure in a population based cohort in Japanese: the Ohasama study. Hypertension Research 27:1–6

    Article  PubMed  CAS  Google Scholar 

  27. Davies E, Holloway C, Ingram M, et al. (1999) Aldosterone excertion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33:703–707

    PubMed  CAS  Google Scholar 

  28. Brand E, Chatelain N, Mulatero P, et al. (1998) Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32:198–204

    PubMed  CAS  Google Scholar 

  29. Tamaki S, Iwai N, Tsujita Y, Kinoshita M (1999) Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 33:266–270

    PubMed  CAS  Google Scholar 

  30. Hautanena A, Lankinen L, Kupari M, et al. (1998) Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med 244:11–18

    Article  PubMed  CAS  Google Scholar 

  31. Connel J, Fraser R, Mackenzie S, Davies E (2003) Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? Hypertension 41:993–999

    Article  CAS  Google Scholar 

  32. Safar M, Cattan V, Lacolley P, et al. (2005) Aldosterone synthase gene polymorphism, stroke volume and age-related changes in aortic pulse wave velocity in subjects with hypertension. J Hypertens 23:1159–1166

    Article  PubMed  CAS  Google Scholar 

  33. Lacolley P, Safar M, Lucet B, et al. (2001) Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol 37:662–667

    Article  PubMed  CAS  Google Scholar 

  34. Schmidt H, Fazeka F, Kostner G, et al. (2001) Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage. Stroke 32:405–412

    PubMed  CAS  Google Scholar 

  35. MacLullich A, Wardlaw J, Ferguson K, et al. (2004) Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry 75:1519–1523

    Article  PubMed  CAS  Google Scholar 

  36. Barkhof F (2004) Enlarged Virchow-Robin spaces: do they matter? J Neurol Neurosurg Psychiatry 75:1516–1517

    Article  PubMed  CAS  Google Scholar 

  37. Udaka F, Sawada H, Kameyama (2002) White matter lesions and dementia. Ann NY Acad Sci 977:411–415

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to P. Amarenco MD.

Additional information

The institutions and investigators in theGENIC (Étude du profil GENétique del’Infarctus Cérébral) study are listed on ourwebsite: http://www.ccr.jussieu.fr/GENIC/Welcome.html.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brenner, D., Labreuche, J., Pico, F. et al. The renin-angiotensin-aldosterone system in cerebral small vessel disease. J Neurol 255, 993–1000 (2008). https://doi.org/10.1007/s00415-008-0816-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0816-8

Key words

Navigation